Corrigendum to “Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways” [Int. Immunopharmacol. 55 (2018) 9–19]
- Resource Type
- Erratum
- Source
- In
International Immunopharmacology 5 January 2024 126 - Subject
- Language
- ISSN
- 1567-5769